查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS | 0.7 2026-12-31 | 0.46 – 0.87 | 3 | +14.10% | +23.07% | +17.85% | 2 / 0 | $949.42B |
| ARGX argenx SE American Depositary Shares | 28.59 2026-12-31 | 25.06 – 37.17 | 15 | +9.64% | +10.40% | +13.80% | 8 / 0 | $6.18B |
| REGN Regeneron Pharmaceuticals Inc. Common Stock | 50.38 2026-12-31 | 45.77 – 58.33 | 20 | +9.87% | +9.01% | +8.63% | 0 / 1 | $16.66B |
| THRM Gentherm Inc Common Stock | 2.92 2026-12-31 | 2.75 – 3.06 | 6 | +7.50% | +7.73% | +9.69% | 6 / 0 | $1.61B |
| GNRC Generac Holdlings Inc. Common Stock | 9.68 2026-12-31 | 9.22 – 10.33 | 15 | +7.22% | +7.37% | +8.11% | 2 / 0 | $4.93B |
| CCC CCC Intelligent Solutions Holdings Inc. Common Stock | 0.47 2026-12-31 | 0.44 – 0.5 | 7 | +5.63% | +5.57% | +7.11% | 10 / 0 | $1.16B |
| GCO Genesco Inc. Common Stock | 2.25 2027-01-31 | 2.2 – 2.3 | 4 | +5.39% | +5.39% | +6.47% | 4 / 0 | $2.43B |
| GNTX Gentex Corporation Common Stock | 2.1 2026-12-31 | 2.06 – 2.15 | 6 | +4.90% | +5.16% | +5.16% | 1 / 0 | $2.67B |
| GM General Motors Company Common Stock | 13.39 2026-12-31 | 11.85 – 15.25 | 25 | +1.79% | +4.34% | +4.66% | 0 / 0 | $185.67B |
| RGEN Repligen Corporation Common Stock | 2.06 2026-12-31 | 2.03 – 2.09 | 19 | +3.14% | +3.11% | +4.89% | 2 / 0 | $826.97M |
| GD General Dynamics Corporation Common Stock | 16.93 2026-12-31 | 16.8 – 17.14 | 15 | +1.37% | +1.53% | +2.10% | 3 / 0 | $55.84B |
| CATY Cathay General Bancorp Common Stock | 5.51 2026-12-31 | 5.36 – 5.63 | 5 | +0.58% | +0.66% | +1.14% | 1 / 0 | $890.55M |
| GPC Genuine Parts Company Common Stock | 7.74 2026-12-31 | 7.6 – 7.85 | 10 | +0.55% | +0.47% | +0.68% | 3 / 4 | $25.54B |
| FPS Forgent Power Solutions Inc. Class A Common Stock | 0.67 2026-06-30 | 0.6 – 0.74 | 10 | -0.08% | +0.46% | +6.84% | 9 / 0 | $1.39B |
| REG Regency Centers Corporation Common Stock | 2.43 2026-12-31 | 2.33 – 2.51 | 6 | 0.00% | +0.45% | +1.21% | 3 / 1 | $1.61B |
| QGEN Qiagen N.V. Common Shares | 2.44 2026-12-31 | 2.43 – 2.5 | 12 | -0.04% | +0.42% | -0.27% | 0 / 0 | $2.15B |
| NIQ NIQ Global Intelligence plc Ordinary Shares | 0.98 2026-12-31 | 0.95 – 1.04 | 14 | 0.00% | +0.26% | +1.25% | 8 / 4 | $4.48B |
| CASY Casey's General Stores Inc. Common Stock | 21.29 2027-04-30 | 20.78 – 22.02 | 17 | +0.06% | +0.25% | +6.56% | 14 / 2 | $20.53B |
| LGN Legence Corp. Class A Common stock | 1.46 2026-12-31 | 0.98 – 2.4 | 8 | 0.00% | +0.09% | +37.67% | 5 / 1 | $4.27B |
| POR Portland General Electric Co Common Stock | 3.39 2026-12-31 | 3.32 – 3.44 | 13 | -0.02% | +0.01% | -0.55% | 1 / 0 | $3.72B |
| DG Dollar General Corporation Common Stock | 7.37 2027-01-31 | 7.2 – 7.55 | 26 | +0.06% | +0.01% | +1.46% | 21 / 0 | $44.41B |
| GEN Gen Digital Inc. Common Stock | 2.9 2027-03-31 | 2.8 – 2.95 | 11 | 0.00% | 0.00% | +0.92% | 6 / 4 | $5.38B |
| GNK Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands) | 2.19 2026-12-31 | 1.33 – 3.2 | 5 | 0.00% | 0.00% | +45.11% | 3 / 0 | $368.52M |
| TEO Telecom Argentina SA | 1.54 2026-12-31 | 1.32 – 1.77 | 3 | 0.00% | 0.00% | +47.19% | 3 / 0 | $6.89B |
| G Genpact Limited Common Stock | 4.07 2026-12-31 | 4 – 4.17 | 12 | 0.00% | -0.02% | +1.35% | 12 / 0 | $5.43B |
| OCTV Octave Intelligence plc Class B Ordinary Shares | 1.4 2026-12-31 | 1.32 – 1.49 | 7 | 0.00% | -0.02% | — | 0 / 0 | $1.66B |
| AMGN Amgen Inc. Common Stock | 22.35 2026-12-31 | 21.7 – 23.11 | 33 | +0.05% | -0.16% | +0.13% | 1 / 0 | $37.74B |
| VGNT Versigent PLC Ordinary Shares | 6.86 2026-12-31 | 5.23 – 8.04 | 11 | +0.23% | -0.93% | +2.41% | 0 / 1 | $9.31B |
| GIS General Mills Inc. Common Stock | 3.08 2027-05-31 | 3 – 3.15 | 19 | -0.54% | -1.67% | -6.21% | 4 / 12 | $17.79B |
| NEOG Neogen Corporation Common Stock | 0.29 2027-05-31 | 0.23 – 0.35 | 3 | -2.22% | -2.22% | -1.13% | 1 / 0 | $866.47M |
| LAR Lithium Argentina AG Common Shares | 0.45 2026-12-31 | 0.31 – 0.6 | 5 | -5.02% | -3.21% | +4.09% | 0 / 0 | $0 |
| BIIB Biogen Inc. Common Stock | 12.46 2026-12-31 | 11.88 – 13.47 | 23 | +3.58% | -6.51% | -7.42% | 1 / 1 | $10.38B |
| AXGN Axogen Inc. Common Stock | 0.44 2026-12-31 | 0.33 – 0.49 | 7 | -9.94% | -9.94% | -9.94% | 1 / 4 | $279.53M |
| ALLO Allogene Therapeutics Inc. Common Stock | -0.61 2026-12-31 | -0.66 – -0.58 | 5 | — | — | — | 2 / 1 | $6.67K |
| CCOI Cogent Communications Holdings Inc. | -3.92 2026-12-31 | -5.06 – -3.16 | 4 | — | — | — | 1 / 1 | $963.53M |
| COGT Cogent Biosciences Inc. Common Stock | -2.26 2026-12-31 | -2.7 – -1.96 | 10 | — | — | — | 2 / 7 | $9.9M |
| ENGN enGene Therapeutics Inc. Common Stock | -1.73 2026-10-31 | -1.95 – -1.56 | 9 | — | — | — | 9 / 0 | $0 |
| GENB Generate Biomedicines Inc. Common Stock | -2.24 2026-12-31 | -2.4 – -2.11 | 4 | — | — | — | 0 / 3 | $25.89M |
| GNLX Genelux Corporation Common Stock | -0.82 2026-12-31 | -0.91 – -0.74 | 6 | — | — | — | 1 / 4 | $0 |
| IMA ImageneBio Inc. Common Stock | -4.1 2026-12-31 | -5.39 – -3.35 | 3 | — | — | — | 0 / 2 | $0 |
| IRD Opus Genetics Inc. Common Stock | -1.02 2026-12-31 | -1.31 – -0.2 | 13 | — | — | — | 0 / 2 | $14.87M |
| MGX Metagenomi Therapeutics Inc. Common Stock | -2.16 2026-12-31 | -2.24 – -2.03 | 3 | — | — | — | 1 / 2 | $10.25M |
| MYGN Myriad Genetics Inc. Common Stock | 0.05 2026-12-31 | -0.06 – 0.09 | 9 | — | — | — | 4 / 3 | $863.56M |
| NEO NeoGenomics Inc. Common Stock | 0.18 2026-12-31 | 0.16 – 0.2 | 11 | — | — | — | 3 / 3 | $804.16M |
| NGEN NervGen Pharma Corp. Common stock | -0.27 2026-12-31 | -0.29 – -0.23 | 4 | — | — | — | 2 / 0 | $0 |
| NGNE Neurogene Inc. Common Stock | -5.31 2026-12-31 | -5.89 – -4.8 | 6 | — | — | — | 1 / 0 | $0 |
| NXE Nexgen Energy Ltd. Common Shares | -0.35 2026-12-31 | -0.47 – -0.22 | 7 | — | — | — | 0 / 5 | $0 |
| OCGN Ocugen Inc. Common Stock | -0.22 2026-12-31 | -0.25 – -0.18 | 6 | — | — | — | 2 / 4 | $4.37M |
| PEPG PepGen Inc. Common Stock | -1.14 2026-12-31 | -1.49 – -1 | 7 | — | — | — | 3 / 1 | $0 |
| PGEN Precigen Inc. Common Stock | -0.03 2026-12-31 | -0.06 – 0.02 | 3 | — | — | — | 2 / 0 | $124.43M |
| RARE Ultragenyx Pharmaceutical Inc. Common Stock | -4.19 2026-12-31 | -4.27 – -4.12 | 3 | — | — | — | 0 / 2 | $748.3M |
| RGNX REGENXBIO Inc. Common Stock | -2.79 2026-12-31 | -4.91 – 1.61 | 8 | — | — | — | 2 / 1 | $237.89M |
| TSHA Taysha Gene Therapies Inc. Common Stock | -0.44 2026-12-31 | -0.54 – -0.36 | 5 | — | — | — | 1 / 1 | $1.85M |
| URGN UroGen Pharma Ltd. Ordinary Shares | -0.71 2026-12-31 | -1.7 – -0.15 | 8 | — | — | — | 1 / 0 | $276.49M |
| WGS GeneDx Holdings Corp. Class A Common Stock | -0.06 2026-12-31 | -0.69 – 0.09 | 8 | — | — | — | 0 / 2 | $478.38M |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。